These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 27549100)

  • 1. Findings of ulceration and severe stricture on MRE can predict prognosis of Crohn's disease in patients treated with anti-TNF treatment.
    Naganuma M; Okuda S; Hisamatsu T; Matsuoka K; Mori K; Hosoe N; Nakazato Y; Ogata H; Kanai T
    Abdom Radiol (NY); 2017 Jan; 42(1):141-151. PubMed ID: 27549100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of anti-TNF therapy on the magnetic resonance enterographic parameters of Crohn's disease activity.
    Eder P; Katulska K; Krela-Kaźmierczak I; Stawczyk-Eder K; Klimczak K; Szymczak A; Linke K; Łykowska-Szuber L
    Abdom Imaging; 2015 Oct; 40(7):2210-8. PubMed ID: 26048698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance enterography changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn's disease: correlation with SES-CD and clinical-biological markers.
    Stoppino LP; Della Valle N; Rizzi S; Cleopazzo E; Centola A; Iamele D; Bristogiannis C; Stoppino G; Vinci R; Macarini L
    BMC Med Imaging; 2016 May; 16(1):37. PubMed ID: 27149857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion-weighted magnetic resonance enterocolonography in predicting remission after anti-TNF induction therapy in Crohn's disease.
    Buisson A; Hordonneau C; Goutte M; Scanzi J; Goutorbe F; Klotz T; Boyer L; Pereira B; Bommelaer G
    Dig Liver Dis; 2016 Mar; 48(3):260-6. PubMed ID: 26699828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease.
    Ordás I; Rimola J; Rodríguez S; Paredes JM; Martínez-Pérez MJ; Blanc E; Arévalo JA; Aduna M; Andreu M; Radosevic A; Ramírez-Morros AM; Pinó S; Gallego M; Jauregui-Amezaga A; Ricart E; Panés J
    Gastroenterology; 2014 Feb; 146(2):374-82.e1. PubMed ID: 24177375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in dynamic contrast-enhanced pharmacokinetic and diffusion-weighted imaging parameters reflect response to anti-TNF therapy in Crohn's disease.
    Bhatnagar G; Dikaios N; Prezzi D; Vega R; Halligan S; Taylor SA
    Br J Radiol; 2015; 88(1055):20150547. PubMed ID: 26402217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of infliximab therapy on transmural lesions as assessed by magnetic resonance enteroclysis in patients with ileal Crohn's disease.
    Van Assche G; Herrmann KA; Louis E; Everett SM; Colombel JF; Rahier JF; Vanbeckevoort D; Meunier P; Tolan D; Ernst O; Rutgeerts P; Vermeire S; Aerden I; Oortwijn A; Ochsenkühn T
    J Crohns Colitis; 2013 Dec; 7(12):950-7. PubMed ID: 23411006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small-Bowel Crohn Disease Treated With Anti-Tumor Necrosis Factor-α Therapy: MR Enterography Score Changes After 1 Year Predict Long-Term Outcomes.
    Gallego JC; de Juan C; Echarri A; Lopez-de-Ullibarri I
    AJR Am J Roentgenol; 2019 Dec; 213(6):1240-1246. PubMed ID: 31414894
    [No Abstract]   [Full Text] [Related]  

  • 9. Magnetic resonance enterography findings as predictors of clinical outcome following antitumor necrosis factor treatment in small bowel Crohn's disease.
    Gibson DJ; Murphy DJ; Smyth AE; McEvoy SH; Keegan D; Byrne K; Mulcahy HE; Cullen G; Malone DE; Doherty GA
    Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):956-62. PubMed ID: 26049706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infliximab Exposure Associates With Radiologic Evidence of Healing in Patients With Crohn's Disease.
    Bossuyt P; Dreesen E; Rimola J; Devuysere S; De Bruecker Y; Vanslembrouck R; Laurent V; Zappa M; Savoye-Collet C; Pariente B; Filippi J; Baert F; D'Haens G; Laharie D; Peyrin-Biroulet L; Vermeire S;
    Clin Gastroenterol Hepatol; 2021 May; 19(5):947-954.e2. PubMed ID: 32360982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent damage on magnetic resonance enterography in patients with Crohn's disease in endoscopic remission.
    Rimola J; Alfaro I; Fernández-Clotet A; Castro-Poceiro J; Vas D; Rodríguez S; Masamunt MC; Ordás I; Ricart E; Panés J
    Aliment Pharmacol Ther; 2018 Dec; 48(11-12):1232-1241. PubMed ID: 30345577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance enterography for predicting the clinical course of Crohn's disease strictures.
    Schulberg JD; Wright EK; Holt BA; Sutherland TR; Hume SJ; Hamilton AL; Ross AL; Connell WC; Brown SJ; Lust M; Miller AM; Bell SJ; Kamm MA
    J Gastroenterol Hepatol; 2020 Jun; 35(6):980-987. PubMed ID: 31674069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-treatment magnetic resonance enterography findings predict the response to TNF-alpha inhibitors in Crohn's disease.
    Rimola J; Fernàndez-Clotet A; Capozzi N; Rojas-Farreras S; Alfaro I; Rodríguez S; Masamunt MC; Ricart E; Ordás I; Panés J
    Aliment Pharmacol Ther; 2020 Nov; 52(10):1563-1573. PubMed ID: 32886809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging may predict deep remission in patients with perianal fistulizing Crohn's disease.
    Thomassin L; Armengol-Debeir L; Charpentier C; Bridoux V; Koning E; Savoye G; Savoye-Collet C
    World J Gastroenterol; 2017 Jun; 23(23):4285-4292. PubMed ID: 28694669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic response to tumor necrosis factor inhibitors predicts long term benefits in Crohn's disease.
    Alfaro I; Masamunt MC; Planell N; López-García A; Castro J; Gallego M; Barastegui R; Giner A; Vara A; Salas A; Ricart E; Panés J; Ordás I
    World J Gastroenterol; 2019 Apr; 25(14):1764-1774. PubMed ID: 31011260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of Magnetic Resonance Enterography For Small Bowel Endoscopic Healing in Patients With Crohn's Disease.
    Takenaka K; Ohtsuka K; Kitazume Y; Matsuoka K; Nagahori M; Fujii T; Saito E; Kimura M; Fujioka T; Watanabe M
    Am J Gastroenterol; 2018 Feb; 113(2):283-294. PubMed ID: 29257147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy of intestinal ultrasound and magnetic resonance enterography for the detection of endoscopy-based disease activity in ileocolonic Crohn's disease.
    Yuksel I; Kilincalp S; Coskun Y; Akinci H; Hamamci M; Alkan A
    Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):809-816. PubMed ID: 31094855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Transmural Response Assessed Using Magnetic Resonance Imaging Could Predict Sustained Clinical Remission and Prevent Bowel Damage in Patients with Crohn's Disease Treated with Anti-Tumour Necrosis Factor Therapy.
    Messadeg L; Hordonneau C; Bouguen G; Goutorbe F; Reimund JM; Goutte M; Boucher AL; Scanzi J; Reymond M; Allimant C; Dapoigny M; Pereira B; Bommelaer G; Buisson A
    J Crohns Colitis; 2020 Nov; 14(11):1524-1534. PubMed ID: 32533769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of Surveillance MR Enterography (MRE) in Asymptomatic Children and Adolescents With Crohn's Disease.
    Chu KF; Moran CJ; Wu K; Kaplan JL; Savarino JR; Board T; Israel EJ; Winter HS; Gee MS
    J Magn Reson Imaging; 2019 Dec; 50(6):1955-1963. PubMed ID: 31145502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic Severity Predicts Long-Term Prognosis in Crohn's Disease Patients with Clinical Remission.
    Naganuma M; Hisamatsu T; Matsuoka K; Kiyohara H; Arai M; Sugimoto S; Mori K; Nanki K; Ohno K; Mutaguchi M; Mizuno S; Bessho R; Nakazato Y; Hosoe N; Inoue N; Iwao Y; Ogata H; Kanai T
    Digestion; 2016; 93(1):66-71. PubMed ID: 26789838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.